Filter your results
- 3
- 3
- 3
- 1
- 1
- 1
- 1
- 3
- 3
- 3
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
⁹⁰Y-labelled anti-CD22 epratuzumab tetraxetan in adults with refractory or relapsed CD22-positive B-cell acute lymphoblastic leukaemia: a phase 1 dose-escalation studyThe Lancet, 2015, 2 (3), pp.e108-17. ⟨10.1016/S2352-3026(15)00020-4⟩
Journal articles
inserm-02913620v1
|
||
|
Assessment of acquisition protocols for routine imaging of Y-90 using PET/CT.EJNMMI Research, 2013, 3 (1), pp.11. ⟨10.1186/2191-219X-3-11⟩
Journal articles
inserm-00806787v1
|
||
|
Radioimmunotherapy for Treatment of Acute LeukemiaSeminars in Nuclear Medicine, 2016, 46, pp.135-146. ⟨10.1053/j.semnuclmed.2015.10.007⟩
Journal articles
inserm-01280232v1
|